Dec 16, 2025 12:18PM

Mar 20, 2025 04:22PM

Nov 6, 2024 04:06PM

Sep 23, 2024 07:31AM

Sep 23, 2024 07:30AM

Aug 7, 2024 04:17PM

Aug 1, 2024 07:31AM Context Therapeutics (CNTX) Appoints Claudio Dansky Ullmann as Chief Medical Officer

Aug 1, 2024 07:30AM

Jul 11, 2024 10:30AM

Jul 10, 2024 07:30AM

Jul 10, 2024 07:30AM

May 8, 2024 04:06PM

May 2, 2024 07:32AM

May 2, 2024 07:31AM Context Therapeutics Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of CTIM-76

Apr 1, 2024 07:30AM

Mar 21, 2024 07:43AM

Nov 9, 2023 04:15PM

Jan 31, 2023 07:30AM

Jan 31, 2023 07:30AM

Jan 31, 2023 07:30AM

Jan 4, 2023 07:30AM Context Therapeutics® Highlights 2023 Corporate Priorities and Pipeline Milestones

Jan 4, 2023 07:30AM

Nov 29, 2022 07:31AM

Nov 29, 2022 07:30AM

Nov 29, 2022 07:30AM

Sep 27, 2022 07:30AM

Sep 27, 2022 07:30AM

Dec 3, 2019 08:00AM Centrexion Therapeutics Announces Issuance of U.S. Composition of Matter Patent for Lead Pipeline Candidate CNTX-4975

Nov 8, 2019 08:00AM

Sep 17, 2019 08:02AM

Sep 17, 2019 08:00AM

Sep 4, 2019 11:11AM

Sep 4, 2019 11:11AM

Sep 4, 2019 08:00AM

Jul 18, 2019 07:30AM Centrexion Therapeutics to Present New Positive Clinical Trial Results on Streamlined CNTX-4975 Administration Techniques

Jun 11, 2019 07:30AM

Jun 5, 2019 07:30AM

Apr 29, 2019 08:25AM

Mar 27, 2019 07:30AM

Mar 7, 2019 07:30AM

Dec 5, 2018 07:30AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All